Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1587 of 5804
-
HPV Vaccine's Real-World impact under the microscope in sikkim
Prevention Recruiting nowThis project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of…
Sponsor: International Agency for Research on Cancer • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Diabetes drug semaglutide may help people with leg pain walk longer
Symptom relief CompletedThis study is done to see if semaglutide has an effect on walking ability compared with placebo (dummy medicine) in people with peripheral arterial disease (PAD) and type 2 diabetes. Participants will either get semaglutide or placebo ("dummy") medicine - which treatment particip…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Could a cheap pill replace IV drips for ulcer bleeding?
Disease control Recruiting nowPeptic ulcer bleeding is the most common etiology in upper gastrointestinal bleeding all over the world. After endoscopic treatment, proton pump inhibitor (PPI) is recommended to prevent re-bleeding. Intravenous PPI is recommended as a standard treatment. In the past, there were …
Phase: NA • Sponsor: King Chulalongkorn Memorial Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:53 UTC
-
New implant aims to improve shoulder surgery outcomes
Disease control Recruiting nowThis prospective, single-arm, multicenter registry is being conducted to collect real world post-market data from patients who are undergoing rotator cuff repair using the REGENETEN◊ Bioinductive Implant System. The Registry will include up to 50 centers in the United Kingdom (UK…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New targeted pill takes on Hard-to-Treat cancers with IDH mutations
Disease control OngoingThis is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitrate dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chond…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a common cholesterol drug help fight a rare liver disease?
Disease control OngoingThis is a randomized, double-blind, placebo controlled multicenter study. A total of 700 patients will be included. After an updated powercalculation 560 was condidered enough The study will include patients with primary sclerosing cholangitis (PSC) for daily intake of 40 mg si…
Phase: PHASE3 • Sponsor: Annika Bergquist • Aim: Disease control
Last updated Jun 26, 2026 13:35 UTC
-
Brain scans after stroke may unlock secrets of cognitive decline
Knowledge-focused OngoingThe investigators will perform follow-up on 250 of 500 cases recruited into the ROSE study of cases with deep and lobar intracerebral hemorrhage to perform advanced neuroimaging at 12-24 months post stroke, and evaluations of motor and cognitive function at baseline, 6 months aft…
Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could Lab-Grown eye cells restore sight? new trial begins
Disease control OngoingThis phase I study will collect preliminary information on the activity and safety of cLSC. We will investigate the ability to manufacture and transplant cLSC onto the cornea successfully at the time of surgery (feasibility), and have cLSC begin to populate the ocular surface (ef…
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New pill targets Alzheimer's in High-Risk gene carriers
Disease control CompletedThe study will investigate the effects of oral ALZ-801, in subjects with Early AD who have the APOE4/4 or APOE3/4 genotype, on the biomarkers of core AD pathology. The objectives of this study include determining the efficacy and safety/tolerability of ALZ-801. In addition, the s…
Phase: PHASE2 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Magnetic pulses to the brain: a new hope for depression?
Symptom relief CompletedThis is a randomized, double-blind, sham-controlled multicenter clinical trial. The aim is to provide evidence for efficacy of TBS in the treatment of patients with major depression. There will be a direct comparison between combined cTBS/iTBS with sham TBS. Overall, 236 patients…
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Symptom relief
Last updated Jun 26, 2026 17:29 UTC
-
New therapy targets Brain's 'Orienting' reflex to treat PTSD
Symptom relief OngoingThis study will evaluate the efficacy of a therapeutic treatment, Deep Brain Reorienting (DBR), for PTSD (Post-traumatic Stress Disorder). Participants will be randomized to either the DBR treatment, or wait-list condition.
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Could a common laxative soothe gut inflammation in cystic fibrosis?
Disease control TerminatedThe main objective of the study is to evaluate the effectiveness of polyethylene glycol treatment on intestinal inflammation in children with cystic fibrosis. In this test, a method adapted from the Fleming one-step scheme will be used. The success rate is measured by the proport…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for tough leukemia: experimental drug combo enters human testing
Disease control Recruiting nowThe purpose of this study is to assess the safety, pharmacokinetic profile of Lisaftoclax (APG-2575) single agent and in combination with HHT/AZA in patients with relapsed/refractory AML and related myeloid malignancies.
Phase: PHASE1, PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Red light therapy shows promise for Kids' eyesight
Prevention OngoingTo evaluate the long-term efficacy of repeated low-level red-light (RLRL) therapy in the prevention and control of myopia in children, and to analyze the key factors influencing its efficacy (such as individual differences and compliance), with the aim of providing evidence-based…
Sponsor: Ruihua Wei • Aim: Prevention
Last updated Jun 26, 2026 14:54 UTC
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control TerminatedThis is a parallel-arm, double-blind, placebo-controlled study with a screening phase that includes a 28-day run-in phase to establish baseline seizure frequency, followed by a 24-week, randomized, placebo-controlled phase. After completion of the randomized, placebo-controlled p…
Phase: PHASE2, PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
ALS drug trial halted: what happened with BIIB105?
Disease control TerminatedThe ALSpire Study is a clinical trial evaluating the investigational drug BIIB105 in adults living with amyotrophic lateral sclerosis (ALS). The ALSpire Study consists of two parts: * Part 1: 6-month placebo-controlled study. During Part 1, participants are randomly assigned to…
Phase: PHASE1, PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Robot surgeons take on pancreatic cancer in major trial
Disease control CompletedThis multicenter randomized trial aims to primarily assess and compare the functional recovery of patients who undergo open versus robotic pancreaticoduodenectomy for benign and malignant lesions of the head of the pancreas.
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for advanced breast cancer patients after chemotherapy fails
Disease control CompletedThis is a multicenter phase 2 study evaluating the efficacy and safety of trifluridine/tipiracil in women with metastatic or locally advanced breast cancer not amenable to curative treatment by surgery or radiotherapy.
Phase: PHASE2 • Sponsor: Borstkanker Onderzoek Groep • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New vaccine shows promise for rare eye cancer
Disease control CompletedA Phase I vaccination trial in patients suffering from recently diagnosed metastatic uveal melanoma not cureable with local therapy and needing systemic therapy. IKKb-matured Dendritic Cells loaded with autologous tumor-RNA + RNA coding for defined antigens and driver mutations w…
Phase: PHASE1 • Sponsor: Hasumi International Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New combo therapy aims to outsmart resistant breast cancer
Disease control OngoingThis phase Ib trial studies the best dose of berzosertib when given together with the usual treatment (radiation therapy) in treating patients with triple negative or estrogen receptor and/or progesterone receptor positive, HER-2 negative breast cancer. Berzosertib may stop the g…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC